CYTOKINETICS INC (CYTK) Institutional Shareholders

CYTOKINETICS INC (CYTK) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $11.75B in CYTK holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of CYTK tracked by InsiderSet, reporting ownership valued at approximately $1.71B in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $1.49B, representing an estimated loss of -12.98% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 49% of the total disclosed CYTK value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Wellington Management Group Llp, Vanguard Portfolio Management Llc, and several other long-term asset managers with concentrated positions in CYTOKINETICS INC (CYTK).

This page ranks the largest institutional CYTK shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

469

Total Reported Value

$11.75B

Largest Holder

Blackrock, Inc.

Largest Position

$1.71B

Insider Transactions (90d)

45

Latest Filing Quarter

Q2 2026

New Institutional Positions

67

Funds Exiting Positions

0

Page 1 of 10
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.03%20,094,362$1,711,838,738$1,489,595,055-$222,243,683-12.98%
Wellington Management Group Llp0.10%6,931,770$590,517,486$513,852,110-$76,665,376-12.98%
Vanguard Portfolio Management Llc0.03%6,711,799$571,778,157$497,545,660-$74,232,497-12.98%
State Street Corp0.02%6,494,233$553,243,709$481,417,492-$71,826,217-12.98%
Vanguard Capital Management Llc0.01%6,117,515$521,151,103$453,491,387-$67,659,716-12.98%
Fmr Llc0.02%5,031,782$428,657,534$373,006,000-$55,651,534-12.98%
Avoro Capital Advisors Llc3.82%4,999,999$425,949,915$370,649,926-$55,299,989-12.98%
Bank Of America Corp0.03%4,635,709$394,916,049$343,645,108-$51,270,941-12.98%
Geode Capital Management, Llc0.02%3,712,501$316,325,896$275,207,699-$41,118,197-13.00%
Rtw Investments, Lp2.08%2,862,003$243,814,036$212,160,282-$31,653,754-12.98%
Polar Capital Holdings Plc0.54%2,253,649$191,988,358$167,063,000-$24,925,358-12.98%
Goldman Sachs Group Inc0.02%1,761,588$150,069,725$130,586,518-$19,483,207-12.98%
Capital Research Global Investors0.02%1,686,625$143,683,584$125,029,511-$18,654,073-12.98%
Northern Trust Corp0.02%1,647,345$140,337,319$122,117,685-$18,219,634-12.98%
Jpmorgan Chase & Co0.01%1,588,895$139,150,046$117,784,786-$21,365,260-15.35%
William Blair Investment Management, Llc0.41%1,603,442$136,597,224$118,863,155-$17,734,069-12.98%
Integral Health Asset Management, Llc5.59%1,600,000$136,304,000$118,608,000-$17,696,000-12.98%
Point72 Asset Management, L.P.0.21%1,587,712$135,257,185$117,697,091-$17,560,094-12.98%
Charles Schwab Investment Management Inc0.02%1,565,781$133,388,883$116,071,346-$17,317,537-12.98%
Sixth Street Partners Management Company, L.P.0.02%1,565,781$133,388,883$116,071,346-$17,317,537-12.98%
Susquehanna International Group, Llp0.12%1,549,458$131,998,327$114,861,322-$17,137,005-12.98%
Morgan Stanley0.01%1,510,318$128,664,004$111,959,873-$16,704,131-12.98%
Principal Financial Group Inc0.05%1,311,664$111,740,656$97,233,652-$14,507,004-12.98%
Capital International Investors0.02%1,305,848$111,245,191$96,802,512-$14,442,679-12.98%
Invesco Ltd.0.01%1,235,323$105,237,167$91,574,494-$13,662,673-12.98%
Armistice Capital, Llc2.83%1,201,342$102,342,325$89,055,482-$13,286,843-12.98%
Ubs Group Ag0.02%1,171,287$99,781,940$86,827,505-$12,954,435-12.98%
Pictet Asset Management Holding Sa0.09%1,160,463$99,038,455$86,025,122-$13,013,333-13.14%
Frazier Life Sciences Management, L.P.2.15%1,159,879$98,810,092$85,981,830-$12,828,262-12.98%
Bank Of New York Mellon Corp0.02%1,150,697$98,027,901$85,301,169-$12,726,732-12.98%
Holocene Advisors, Lp0.22%1,144,579$97,506,685$84,847,641-$12,659,044-12.98%
Woodline Partners Lp0.29%1,100,708$93,769,315$81,595,484-$12,173,831-12.98%
D. E. Shaw & Co., Inc.0.06%1,048,103$89,287,894$77,695,875-$11,592,019-12.98%
Norges Bank0.01%1,015,522$86,512,319$75,280,646-$11,231,673-12.98%
Royalty Pharma Sub-Manager, Llc34.52%980,392$83,519,594$72,676,459-$10,843,135-12.98%
Nomura Asset Management International Inc.0.12%961,815$81,937,000$71,299,346-$10,637,654-12.98%
Vanguard Fiduciary Trust Co0.02%906,423$77,218,175$67,193,137-$10,025,038-12.98%
Bnp Paribas Asset Management Holding S.A.0.07%827,810$70,521,134$61,365,555-$9,155,579-12.98%
Melqart Asset Management (Uk) Ltd6.22%767,525$65,385,455$56,896,628-$8,488,827-12.98%
Siren, L.L.C.1.31%758,952$64,655,121$56,261,112-$8,394,009-12.98%
Fisher Asset Management, Llc0.02%743,697$63,355,547$55,130,259-$8,225,288-12.98%
Foresite Capital Management Iv, Llc20.98%714,695$60,884,867$52,980,340-$7,904,527-12.98%
Balyasny Asset Management L.P.0.11%711,676$60,627,678$52,756,542-$7,871,136-12.98%
Deep Track Capital, Lp0.88%700,000$59,633,000$51,891,000-$7,742,000-12.98%
Bnp Paribas Financial Markets0.03%689,077$58,702,470$51,081,278-$7,621,192-12.98%
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.3.08%660,310$56,251,809$48,948,780-$7,303,029-12.98%
Citadel Advisors Llc0.03%640,945$54,602,105$47,513,253-$7,088,852-12.98%
Qube Research & Technologies Ltd0.05%572,535$48,774,257$42,442,020-$6,332,237-12.98%
Brown Advisory Inc0.08%570,664$48,614,900$42,303,322-$6,311,578-12.98%
Eventide Asset Management, Llc0.64%564,398$48,081,832$41,838,824-$6,243,008-12.98%

Frequently asked questions about CYTK

  • Who owns the most CYTK stock?

    The largest holders of CYTK are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CYTOKINETICS INC (CYTK).

  • Is CYTK widely held by superinvestors?

    Many widely followed stocks like CYTK appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CYTK is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.